Purchase Order 75N92025P00068
Award Date
2/10/25
Potential Completion Date
2/9/26
Potential Value
$229K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Psomagen Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for $24,940.00 and was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Psomagen Inc., a for-profit manufacturer of genomics and molecular biology services. The contract is a Firm Fixed Price Purchase Order to provide the NHLBI's Sickle Cell Branch with the Olink assay, which will be used to study the profiling of plasma proteins among individuals with sickle cell disease. The contract has no set-aside designation and is...
The National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), awarded a $10,620 firm fixed price purchase order to Proteogenix, a for-profit manufacturer of biotechnology products and services. The contract provides additional laboratory screening services to support the development of novel gene therapy by the NHLBI's Center for Molecular Therapeutics and Bioanalytics (CMTB). This award is not associated with a larger contract vehicle and does not have...
This $24,940 firm-fixed-price purchase order was awarded by the National Heart Lung and Blood Institute, a civilian agency, to Psomagen Inc., a for-profit manufacturer of genomic and molecular biology services. The contract is to provide the Olink Explore HT platform to support the Sickle Cell Branch's efforts to detect proteomic biomarkers in individuals with sickle cell disease. The award does not have a set-aside designation. Psomagen has previously received other federal contract awards...
This is a $24,940 firm-fixed-price purchase order awarded by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) to Psomagen Inc., a genomics and molecular biology services company, to provide products for proteomic analysis on sickle cell plasma as part of ongoing sickle cell research efforts. The contract has an ultimate completion date of December 5, 2025. Psomagen Inc. is a subsidiary of Macrogen, Inc. and a for-profit manufacturer of goods that...
This is a $24,940 firm-fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, to Psomagen Inc., a for-profit manufacturer of goods. The contract is for high-throughput, sensitive, and specific protein quantification analysis to maintain the integrity of Batch 3 of sickle cell disease (SCD) patient samples for the NHLBI's Laboratory of Sickle Cell Genetics and Pathophysiology....
The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), awarded a $34,966 firm fixed-price purchase order to Mission Bio, Inc., a for-profit manufacturer of biological supplies and sequencing services. The contract is for the delivery of Tapestri Single-Cell DNA + Protein Reagent Kits to support NHLBI's biomedical research and genomics efforts. The contract has a performance period through December 19, 2025 and does not utilize any...
The National Heart, Lung and Blood Institute of the National Institutes of Health, Department of Health and Human Services, awarded a $224,000 purchase order to Cell Signaling Technology, Inc. of Danvers, Massachusetts for proteome analysis services. The one-year contract, running from August 2024 through August 2025, is for a firm fixed price and will be performed in Danvers. As part of its mission to advance scientific and medical achievements that eliminate preventable disease, the NHLBI...
The National Heart Lung and Blood Institute (NHLBI) awarded a $81,200.00 firm fixed price purchase order contract to Second Genome, Inc. for MICROBIOME OPTIMIZED DNA ISOLATION SERVICES. The contract has a completion date of August 27, 2018 and is designated as a Total Small Business set-aside. Second Genome, Inc. is a self-certified small disadvantaged business. The NHLBI is a civilian agency that conducts and supports research related to the causes, prevention, diagnosis, and treatment of...
This federal contract award, valued at $76,361.60, was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services. The award is a Delivery Order placed under the Multiple Award Schedule (MAS) contract vehicle. The contract was awarded to Government Scientific Source Inc., a for-profit small business organization, to provide a single-cell multiome reagent bundle, single-cell 3' kit V3.1, Chip G kit, Chip J kit, single...
This contract was awarded by the National Heart, Lung and Blood Institute (NHLBI), a civilian agency of the U.S. government, to Astrix Technology LLC, a for-profit limited liability company. The contract is a delivery order valued at $118,386.85 and has an ultimate completion date of May 23, 2025. The purpose of the contract is to provide staffing for a clinical researcher to expand the research capacity in the lab, which will enable continued research in important areas of gene therapy for...